Branch Teams Up With Facebook to Improve Ad Campaign Effectiveness
Measuring ad campaign performance in the digital ecosystem is a tall task. That's why Branch, a company that helps brands optimize their mobile experience, is launching a new tool called 'Universal Ads' and is teaming up with Facebook in a Mobile Measurement Partnership. Eric Stein, Chief Revenue Officer at Branch, joined us to explain how this will help brands measure the true impact of mobile advertising.
Stein explained the incentive for Facebook to team up with Branch. He said Facebook needs third parties to measure the impact of campaigns because Facebook "can't grade its own homework." Branch wants to be looked at as an objective source of information.
Campaign effectiveness is difficult to measure. Brands are spending millions of dollars on campaigns. Due to the many platforms that campaigns run on, it is even harder to gain insights. Stein shares how Branch makes it easier for brands to get a grip on the success of their marketing efforts.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
